A recent report published by Infinium Global Research on cancer vaccines market provides in depth analysis of segments and sub-segments in
global as well as regional markets of cancer vaccines market. Cancer vaccine either treats cancer or prevents development of cancer. Vaccines
that treat existing cancer are known as therapeutic cancer vaccines. Cancer vaccine uses weakened or killed germs such as viruses or bacteria to
start an immune response in the body. With the help of these viruses the immune system gets stronger to fight against the infections. Some
traditional vaccines such as human papilloma virus and hepatitis B virus help prevent victims from cancers. These types of vaccines are useful for
the cancer caused through infections. A number of common etiologic factors have been strongly characterized as raising the risk of developing
cancer including age, chronic inflammation, gender, obesity, tobacco usage and heritable cancer syndromes. There are two types of cancer
vaccines namely prevention vaccines and treatment vaccines. Prevention vaccines are given to healthy people to keep certain cancers from
developing like viruses for chickenpox and flu they protect the body that can cause disease. Cancer treatment vaccines are the type of vaccines
that work to boost the body’s immune system to fight against cancer. Doctors give treatment vaccines to prevent the cancer from reoccurring,
destroy the cancer cells after the treatment has been taken and as well stop a tumour from growing and coming back. The cancer treatment
vaccine works as; there are some substances on the surface of the cells called as Antigens. These Antigens are never the part of human body and
hence they attack the immune system and this immune system helps to respond against those Antigens in the future. Cancer treatment vaccines
boost the immune system’s ability to recognise and destroy antigens. Some cancer vaccines are made for each patient they are produced from
the patient’s tumour sample which indicates that surgery is needed to get large amount of tumour sample to create vaccines. According to report
the global cancer vaccines market is projected to grow at a CAGR of 17.8% over the forecast period of 2018 - 2024.
Market insights
According to Cancer Research UK in 2012, around 14.1 million new cancer cases occurred worldwide. The frequency rate of cancer is increasing
due to unhealthy lifestyle, hereditary issues and environmental changes. This huge disease burden will drive the market in the forecast period.
The global market is driven by rise in occurrence of HPV infections and related cancer, increase in administration of prophylactic cancer vaccines,
surge in investments & findings in the development of cancer vaccines, and launch of novel cancer vaccines in the market. The UNICEF and WHO
have published guidelines on developing a national immunization plan, the comprehensive Multi-Year Plan (cMYP) for all nations across the
globe, which expects to ensure fair access to vaccination facilities for all individuals. As compared to the cancer pharmaceutical market the cancer
vaccine market is considered relatively smaller and it is the restraining factor for the growth of cancer vaccine market currently. Moreover, the
strict supervisory factor related to pre and post marketing approvals is another factor hampering the growth of the market. Due to the increase
in demand for preventive cancer vaccines thepaediatric vaccines segment is expected to exhibit high growth rate during forecast period thereby
providing high growth opportunities for the major players in cancer vaccine market.